299 related articles for article (PubMed ID: 10665057)
1. [Isolation of acyclovir-resistant strains of herpes simplex virus from clinical material].
L'vov ND; Andronova VL; Leont'eva NA; Galegov GA
Vopr Virusol; 1999; 44(6):247-9. PubMed ID: 10665057
[TBL] [Abstract][Full Text] [Related]
2. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
3. Screening for acyclovir-resistant herpes simplex virus isolates from clinical samples.
Mah IW; Kuo BI; Wei HY; Tsai CH; Liu WT
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Feb; 30(1):51-4. PubMed ID: 10592810
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2.
Honda M; Okuda T; Hasegawa T; Kurokawa M; Shiraki K; Matsuo K; Komatsuzaki M; Niimura M
Antivir Chem Chemother; 2001 Jul; 12(4):233-9. PubMed ID: 11771732
[TBL] [Abstract][Full Text] [Related]
5. Acyclovir resistant genital herpes virus infection in a patient with AIDS.
Marrero M; Alvarez M; Millan JC; Mas Lago P; Soler M; Diaz M
Acta Virol; 1991 Jan; 35(1):86-9. PubMed ID: 1683121
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
Bernstein DI; Ireland J; Bourne N
Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
Chatis PA; Miller CH; Schrager LE; Crumpacker CS
N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
[No Abstract] [Full Text] [Related]
8. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
[TBL] [Abstract][Full Text] [Related]
9. [In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?].
Losada I; Cañizares A; Hellín T; Martí-Belda P; Guerrero A
Enferm Infecc Microbiol Clin; 2002 Jan; 20(1):25-7. PubMed ID: 11820977
[TBL] [Abstract][Full Text] [Related]
10. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of HSV strains isolated before and after treatment with acyclovir.
Svennerholm B; Vahlne A; Löwhagen GB; Widell A; Lycke E
Scand J Infect Dis Suppl; 1985; 47():149-54. PubMed ID: 3006229
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus].
Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS
Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669
[TBL] [Abstract][Full Text] [Related]
14. Recurrent genital herpes and suppressive oral acyclovir therapy. Relation between clinical outcome and in-vitro drug sensitivity.
Lehrman SN; Douglas JM; Corey L; Barry DW
Ann Intern Med; 1986 Jun; 104(6):786-90. PubMed ID: 3010782
[TBL] [Abstract][Full Text] [Related]
15. Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir.
Safrin S; Schacker T; Delehanty J; Hill E; Corey L
Antimicrob Agents Chemother; 1993 May; 37(5):975-9. PubMed ID: 8390815
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient.
Pardeiro M; Cuenca-Estrella M; Fernández-Clúa MA; Santos-O'Connor F; Tabarés E; Gadea I
J Med Virol; 2004 May; 73(1):60-4. PubMed ID: 15042649
[TBL] [Abstract][Full Text] [Related]
18. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
Field HJ; Neden J
Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
[TBL] [Abstract][Full Text] [Related]
19. A screening dye-uptake assay to evaluate in vitro susceptibility of herpes simplex virus isolates to acyclovir.
Danve C; Morfin F; Thouvenot D; Aymard M
J Virol Methods; 2002 Sep; 105(2):207-17. PubMed ID: 12270654
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]